European shares slip on caution around vaccine trials, stimulus

FAN Editor

October 14, 2020

(Reuters) – European shares headed lower on Wednesday after tumbling in the previous session over a halt in COVID-19 vaccine trials and uncertainty over more U.S. stimulus, with investors also staying away from big bets ahead of talks on a Brexit trade deal.

The pan-European STOXX 600 <.STOXX> was down 0.2% by 0708 GMT, with travel and leisure <.SXTP> and insurance <.SXIP> stocks leading early declines.

Although trading in most country indexes was muted, a weaker pound lifted London’s FTSE 100 <.FTSE> by 0.2% ahead of a UK-imposed Oct. 15 deadline on Brexit negotiations. Growing political friction about the impact of new local COVID-19 restrictions has also hit sentiment.

The European Union would prefer to have a deal, but it is ready in case no agreement can be reached, the Commissioner for the EU’s single market said.

The Italian bourse <.FTMIB> was flat as Prime Minister Giuseppe Conte imposed new restrictions on gatherings, restaurants, sports and school activities.

(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Subhranshu Sahu)

Free America Network Articles

Leave a Reply

Next Post

China is the world's biggest 5G smartphone market. That's why Apple's 5G iPhones are so important

GUANGZHOU, China — Apple’s iPhone 12 range with 5G connectivity is going to be very important in China and key to achieving what analysts are calling an upgrade “supercycle.” 5G refers to next-generation mobile networks promising super-fast data speeds. On Tuesday, Apple unveiled four new 5G-capable iPhone models. While 5G […]

You May Like